Skip to content

Clinical trials

Cognitive Dysfunction trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: Mexico Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20132
20181
20191
20202
20211
20221
20232
20242
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed4
Active, not recruiting4
Recruiting3
Withdrawn1
Enrolling by invitation1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Instituto Mexicano del Seguro Social3
Anahuac University2
Universidad Nacional Autonoma de Mexico2
Brenda Sarahí Beristain Lujano1
Distribuidora Biolife SA de CV1
Instituto Nacional de Cardiologia Ignacio Chavez1
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente1
Jaime Daniel Mondragon1
NYU Langone Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction20
Major Depressive Disorder2
Metabolic Syndrome2
Brain Edema1
Coronary Artery Disease1
Dementia, Vascular1
Heart Failure1
Inflammation1
Insulin Resistance1
Ischemic Stroke1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.